Chimerix Inc. (CMRX)

AI Score

Unlock

8.53

0.00 (0.00%)

At close: Apr 04, 2025, 3:59 PM

8.52

-0.06%

After-hours: Apr 04, 2025, 05:44 PM EDT

Dividends

No dividend history available for Chimerix Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield
Spero Therapeutics, Inc.	0.52%

Dividend Rankings

CMRX News

5 days ago · Biotech Stocks Q1 2025 Recap: Winners And Underperformers - seekingalpha.com
3 weeks ago · CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - businesswire.com
4 weeks ago · The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals - zacks.com
1 month ago · Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More - zacks.com
4 weeks ago · Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio - zacks.com
1 month ago · Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - benzinga.com
1 month ago · Jazz Pharmaceuticals to buy Chimerix for $935 million - reuters.com
1 month ago · Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients - seekingalpha.com
1 month ago · Here's Why Momentum in Chimerix (CMRX) Should Keep going - zacks.com
2 months ago · CMRX Stock Skyrockets in 3 Months: Here's What You Should Know - zacks.com